{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:04:35Z","timestamp":1790597075532,"version":"4.1.0"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>There are currently no effective treatments available for clear cell ovarian cancer (CCC). In this study, we aimed to identify effective drugs for CCC through high-throughput drug screening (HTDS) using ovarian cancer organoids and determine novel therapeutic targets based on the biological characteristics of CCC through omics analysis. An ovarian cancer organoid biobank was established, and HTDS was conducted using CCC organoids based on libraries of 361 and 4,560 compounds. The efficacy of the identified drugs was verified in in vitro and in vivo experiments using a patient-derived organoid xenograft mouse model. Transcriptome analysis was performed to identify genes related to the pathways targeted by the identified drugs in CCC and to assess their potential as therapeutic targets. Proteasome inhibitors and dinaciclib were extracted using HTDS and shown to inhibit tumorigenesis in vitro and in vivo. CCC, like multiple myeloma, exhibited activated endoplasmic reticulum (ER) stress and unfolded protein response (UPR), and treatment with proteasome inhibitors further enhanced ER stress and UPR, ultimately leading to cell death. Transcriptome analysis identified anterior gradient-2 (AGR2) as a key gene involved in UPR in CCC. CRISPR knockout of AGR2 suppressed cell proliferation, increased sensitivity to proteasome inhibitors, and reversed platinum resistance in CCC. AGR2 knockout also upregulated Schlafen 11, contributing to platinum sensitivity. ER stress and the UPR are activated in CCC, and proteasome inhibitors disrupt this balance, ultimately leading to cell death. AGR2 may serve as a potential therapeutic target in CCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Proteasome inhibitors and dinaciclib are identified as effective drugs for CCC. CCC has a high basal UPR, and proteasome inhibition may disrupt this balance. AGR2 is involved in the UPR of CCC, and inhibiting AGR2 further enhances the UPR and confers platinum sensitivity, making it a potential therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0024","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:16:46Z","timestamp":1748935006000},"page":"1018-1033","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9919-1692","authenticated-orcid":false,"given":"Takuma","family":"Yoshimura","sequence":"first","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."},{"name":"2JSR-Keio University Medical and Chemical Innovation Center (JKiC), Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-0513","authenticated-orcid":false,"given":"Takashi","family":"Kamatani","sequence":"additional","affiliation":[{"name":"3Laboratory for Medical Science Mathematics, Department of Biological Sciences, School of Science, The University of Tokyo, Tokyo, Japan."},{"name":"4Department of AI Technology Development, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan."},{"name":"5Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Institute of Science Tokyo Hospital, Tokyo, Japan."},{"name":"6Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9403-2143","authenticated-orcid":false,"given":"Aki","family":"Ookubo","sequence":"additional","affiliation":[{"name":"7JSR-Keio University Medical and Chemical Innovation Center (JKiC), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-6121","authenticated-orcid":false,"given":"Mio","family":"Takahashi","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."},{"name":"2JSR-Keio University Medical and Chemical Innovation Center (JKiC), Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9190-1757","authenticated-orcid":false,"given":"Manabu","family":"Itoh","sequence":"additional","affiliation":[{"name":"7JSR-Keio University Medical and Chemical Innovation Center (JKiC), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2955-6925","authenticated-orcid":false,"given":"Toshiki","family":"Ebisudani","sequence":"additional","affiliation":[{"name":"6Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-4043","authenticated-orcid":false,"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8944-8846","authenticated-orcid":false,"given":"Tomomi","family":"Toyonaga","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8054-0124","authenticated-orcid":false,"given":"Junko","family":"Hamamoto","sequence":"additional","affiliation":[{"name":"6Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5619-5148","authenticated-orcid":false,"given":"Keiko","family":"Saotome","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-086X","authenticated-orcid":false,"given":"Kensuke","family":"Sakai","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-0820","authenticated-orcid":false,"given":"Tomoko","family":"Yoshihama","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8585-3072","authenticated-orcid":false,"given":"Nobuko","family":"Moritoki","sequence":"additional","affiliation":[{"name":"9Electron Microscope Laboratory, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-9043","authenticated-orcid":false,"given":"Shinsuke","family":"Shibata","sequence":"additional","affiliation":[{"name":"9Electron Microscope Laboratory, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-8569","authenticated-orcid":false,"given":"Hiroyuki","family":"Yasuda","sequence":"additional","affiliation":[{"name":"6Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-8137","authenticated-orcid":false,"given":"Toshiro","family":"Sato","sequence":"additional","affiliation":[{"name":"10Department of Integrated Medicine and Biochemistry, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3940-3979","authenticated-orcid":false,"given":"Taka-Aki","family":"Sato","sequence":"additional","affiliation":[{"name":"11Research and Development Center for Precision Medicine, University of Tsukuba, Ibaraki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-8326","authenticated-orcid":false,"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-6057","authenticated-orcid":false,"given":"Wataru","family":"Yamagami","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-7918","authenticated-orcid":false,"given":"Tatsuhiko","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"3Laboratory for Medical Science Mathematics, Department of Biological Sciences, School of Science, The University of Tokyo, Tokyo, Japan."},{"name":"12Laboratory for Medical Science Mathematics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan."},{"name":"13Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8214-2242","authenticated-orcid":false,"given":"Tatsuyuki","family":"Chiyoda","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan."},{"name":"2JSR-Keio University Medical and Chemical Innovation Center (JKiC), Keio University School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"2025072507513928400_bib1","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.3802\/jgo.2020.31.e45","article-title":"A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma","volume":"31","author":"Yamagami","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"2025072507513928400_bib2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"2025072507513928400_bib3","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1002\/cam4.3383","article-title":"Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors","volume":"9","author":"Saotome","year":"2020","journal-title":"Cancer Med"},{"key":"2025072507513928400_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ygyno.2021.07.005","article-title":"ARID1A mutation\/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer","volume":"162","author":"Kuroda","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025072507513928400_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.5849","article-title":"Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas","volume":"256","author":"Heinze","year":"2022","journal-title":"J Pathol"},{"key":"2025072507513928400_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"2025072507513928400_bib7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep"},{"key":"2025072507513928400_bib8","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","article-title":"Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing","volume":"10","author":"Nanki","year":"2020","journal-title":"Sci Rep"},{"key":"2025072507513928400_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.15252\/msb.20177697","article-title":"Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations","volume":"13","author":"Jabs","year":"2017","journal-title":"Mol Syst Biol"},{"key":"2025072507513928400_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41698-023-00463-z","article-title":"The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients","volume":"7","author":"\u00c5kerlund","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2025072507513928400_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat Genet"},{"key":"2025072507513928400_bib12","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.3390\/ijms20184330","article-title":"Systematic identification of characteristic genes of ovarian clear cell carcinoma compared with high-grade serous carcinoma based on RNA-sequencing","volume":"20","author":"Nagasawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025072507513928400_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"GTEx Consortium","year":"2013","journal-title":"Nat Genet"},{"key":"2025072507513928400_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025072507513928400_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2025072507513928400_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025072507513928400_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2025072507513928400_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/onc.2009.470","article-title":"Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes","volume":"29","author":"Yamaguchi","year":"2010","journal-title":"Oncogene"},{"key":"2025072507513928400_bib19","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025072507513928400_bib20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2025072507513928400_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fncir.2019.00029","article-title":"Large-area fluorescence and electron microscopic correlative imaging with multibeam scanning electron microscopy","volume":"13","author":"Shibata","year":"2019","journal-title":"Front Neural Circuits"},{"key":"2025072507513928400_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1844-5","article-title":"Somatic inflammatory gene mutations in human ulcerative colitis epithelium","volume":"577","author":"Nanki","year":"2020","journal-title":"Nature"},{"key":"2025072507513928400_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bjc.2017.228","article-title":"Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma","volume":"117","author":"Itamochi","year":"2017","journal-title":"Br J Cancer"},{"key":"2025072507513928400_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2014-05-573741","article-title":"Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma","volume":"125","author":"Kumar","year":"2015","journal-title":"Blood"},{"key":"2025072507513928400_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"2025072507513928400_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12185-016-2016-0","article-title":"Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma","volume":"104","author":"Ri","year":"2016","journal-title":"Int J Hematol"},{"key":"2025072507513928400_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0002-9378(73)90596-6","article-title":"Ultrastructure and histogenesis of clear cell carcinoma of the ovary","volume":"115","author":"Silverberg","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"2025072507513928400_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajpath.2020.01.010","article-title":"Endoplasmic reticulum stress signaling in cancer cells","volume":"190","author":"Oakes","year":"2020","journal-title":"Am J Pathol"},{"key":"2025072507513928400_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","article-title":"Endoplasmic reticulum stress in malignancy","volume":"25","author":"Clarke","year":"2014","journal-title":"Cancer Cell"},{"key":"2025072507513928400_bib30","doi-asserted-by":"crossref","first-page":"44855","DOI":"10.1074\/jbc.M111.275529","article-title":"Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis","volume":"286","author":"Higa","year":"2011","journal-title":"J Biol Chem"},{"key":"2025072507513928400_bib31","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.1205943109","article-title":"Putative DNA\/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents","volume":"109","author":"Zoppoli","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025072507513928400_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2018.12.009","article-title":"Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers","volume":"35","author":"Ogiwara","year":"2019","journal-title":"Cancer Cell"},{"key":"2025072507513928400_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat Med"},{"key":"2025072507513928400_bib34","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.celrep.2018.03.019","article-title":"Repurposing pan-HDAC inhibitors for ARID1A-mutated ovarian cancer","volume":"22","author":"Fukumoto","year":"2018","journal-title":"Cell Rep"},{"key":"2025072507513928400_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","article-title":"Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma","volume":"2","author":"Wu","year":"2021","journal-title":"Nat Cancer"},{"key":"2025072507513928400_bib36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccell.2023.03.002","article-title":"Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis","volume":"41","author":"Zhou","year":"2023","journal-title":"Cancer Cell"},{"key":"2025072507513928400_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"12","author":"Vincenz","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2025072507513928400_bib38","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"2025072507513928400_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10428190500312196","article-title":"Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells","volume":"47","author":"Nakamura","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"2025072507513928400_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1160\/th15-03-0213","article-title":"High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors","volume":"115","author":"Koizume","year":"2016","journal-title":"Thromb Haemost"},{"key":"2025072507513928400_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","article-title":"Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation","volume":"2","author":"Gulla","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"2025072507513928400_bib42","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","article-title":"Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer","volume":"33","author":"Hamanishi","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025072507513928400_bib43","doi-asserted-by":"crossref","first-page":"1014280","DOI":"10.3389\/fonc.2022.1014280","article-title":"Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer","volume":"12","author":"Howard","year":"2022","journal-title":"Front Oncol"},{"key":"2025072507513928400_bib44","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.18632\/oncotarget.3717","article-title":"Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"2025072507513928400_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/1078-0432.CCR-23-0873","article-title":"Osteosarcoma PDX-derived cell line models for preclinical drug evaluation demonstrate metastasis inhibition by dinaciclib through a genome-targeted approach","volume":"30","author":"Schott","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025072507513928400_bib46","first-page":"5249","article-title":"From development to cancer - an ever-increasing role of AGR2","volume":"11","author":"Jach","year":"2021","journal-title":"Am J Cancer Res"},{"key":"2025072507513928400_bib47","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/onc.2012.346","article-title":"Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development","volume":"32","author":"Chevet","year":"2013","journal-title":"Oncogene"},{"key":"2025072507513928400_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1074\/mcp.M300089-MCP200","article-title":"The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage","volume":"3","author":"Pohler","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"2025072507513928400_bib49","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/onc.2016.459","article-title":"ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation","volume":"36","author":"Dumartin","year":"2017","journal-title":"Oncogene"},{"key":"2025072507513928400_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/1535-7163.MCT-23-0257","article-title":"SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma","volume":"23","author":"Akashi","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"2025072507513928400_bib51","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-20-2694","article-title":"SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243","volume":"81","author":"Murai","year":"2021","journal-title":"Cancer Res"},{"key":"2025072507513928400_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0024\/3612085\/crc-25-0024.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/6\/1018\/3626096\/crc-25-0024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/6\/1018\/3626096\/crc-25-0024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:51:52Z","timestamp":1753444312000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/6\/1018\/763180\/High-Throughput-Drug-Screening-of-Clear-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0024","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29400722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645808","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400734","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400713","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645817","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400746","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645829","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400737","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645826","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400716","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400749","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400728","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645814","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400719","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645811","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645823","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29645820","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400740","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400752","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400731","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29400743","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7893152","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}